GE has already pulled in $100M from Olympics; Dental implant market predicted to grow 10% a year;

 @FierceMedDev: Another day, another Covidien 510(k) clearance, this time for a new bedside monitoring system. Report | Follow @FierceMedDev

 @MarkHFierce: Four years of working with FDA pays off. Proteus gained clearance for a new ingestible sensor. Release | Follow @MarkHFierce

 @DamianFierce: A new pig-flesh-based implant could make certain knee surgeries more successful. More | Follow @DamianFierce

> General Electric ($GE) says it sold about $100 million in medial devices, lights and other power supplies for the London Olympic Games, more than justifying its ongoing sponsorship. Story

> The North American dental implant market should grow at a robust 10% annual rate through 2016, according to a new report from Millennium Research Group. Release

> Patients with diabetes and morbid obesity have a higher risk of infection following hip and knee replacement, according to a new study published in the Journal of Bone and Joint Surgery. Story

> Bracco Diagnostics has secured FDA approval to expand its MultiHance agent for use in angiographic imaging. More

> Vermillion ($VRML) says it has generated positive results from a multi-center clinical study of its new ovarian cancer diagnostic involving 494 patients. Release

> Major state biotechnology lobbying groups in Illinois and Georgia are joining AdvaMed's state medical technology alliance, reflecting the increased interconnection between the biotech and medical device industries. Release

Biotech News

 @FierceBiotech: Models shed light on cocaine-curbing enzymes. More | Follow @FierceBiotech

 @JohnCFierce: Wall Street oddsmakers betting heavily against Lilly's solanezumab. News | Follow @JohnCFierce

 @RyanMFierce: Illumina is poised to grab more bioinformatics dollars with its cloud computing product, eventual app store. Release | Follow @RyanMFierce

> Shire's CEO, business model win accolades. Story

> Merck Serono launches first biotech spinout from Geneva wreckage. More

> Gilead preps late-stage sprint on blockbuster hep C studies. News

> FDA denies Otsuka and Lundbeck's antipsychotic drug. Article

Pharma News

 @FiercePharma: Endocyte poaches Novartis exec David Meek to be its chief commercial officer. Report | Follow @FiercePharma

> Shire CEO sees consumer-goods strategies in pharma's future. More

> Pay-for-delay deals could be upended by the Supreme Court. Article

CRO News

> Beta Pharma to manufacture Sunshine's targeted cancer drug. Story

> Quintiles inks deal to promote COPD drug in U.K. Article

> Analysts: CMO market will double by 2018. News

> 438 died in Indian clinical trials last year. Report

> Covance takes a $12.7M loss in Q2. News

Biotech IT News

> AZ's R&D information chief eyes improved trial success. Story

> Models shed light on cocaine-curbing enzymes. More

> Illumina seeks cut of bioinformatics biz with cloud system. Article

> AstraZeneca taps Amazon-like service for outsourcing research. News

> Complete Genomics, Ingenuity combine forces to understand genomes. Report

And Finally... Researchers and watchdogs are again urging the FDA to re-examine its policies on monitoring medical devices that transmit data wirelessly, warning that many techs are susceptible to tampering and data theft. News